Gary W Ashley

This inventor holds 56 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Biodegradable Hydrogels (CPC class A61K). Top assignees: Kosan Biosciences Incorporated, Prolynx LLC, Northwestern University. Active years: 1997-2025.

USPTO Granted Patents = 56 (Patent Applications = 10)

% Patents Active = 92.9

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 7 (Patent Applications = 12)

Average Co-Inventor Count = 3.0

ph-index = 12

Forward Citations = 704(Granted Patents)

Forward Citations (Not Self Cited) = 638(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

28 out of 110

Kosan Biosciences Incorporated

Northwestern University

patents

4. 2 out of 5,489

Leland Stanford Junior University

patents

5. 1 out of 363

Ortho-Mcneil Pharmaceutical Corp.

patents

6. 2 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2025

Loading Chart...

Areas of Expertise:

Biodegradable Hydrogels

Drug Release

Polyketides

Conjugates

Controlled Release

Macrolides

Antibacterial Agents

Somatostatin Analogues

Dendrimers

Prodrugs

Biosynthesis

Antiinfective Agents

56 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12478680 - HYDROGELS WITH BIODEGRADABLE CROSSLINKING (2025-11-25),

2. 12364771 - Conjugation linkers (2025-07-22),

3. 11454861 - Hydrogels with biodegradable crosslinking (2022-09-27),

4. 11181803 - Hydrogels with biodegradable crosslinking (2021-11-23),

5. 11179470 - Hydrogels with biodegradable crosslinking (2021-11-23),

6. 10413594 - Conjugates of somatostatin analogues (2019-09-17),

7. 10398779 - Hydrogels with biodegradable crosslinking (2019-09-03),

8. 10342792 - Slow-release conjugates of SN-38 (2019-07-09),

9. 10086049 - Conjugates of somatostatin analogues (2018-10-02),

10. 10016411 - Slow-release conjugates of SN-38 (2018-07-10),

11. 9649385 - Hydrogels with biodegradable crosslinking (2017-05-16),

12. 9387254 - Prodrugs and drug-macromolecule conjugates having controlled drug release rates (2016-07-12),

13. 8946405 - Controlled release from solid supports (2015-02-03),

14. 8754190 - Controlled release from macromolecular conjugates (2014-06-17),

15. 8703907 - Controlled drug release from dendrimers (2014-04-22),

Title: The Inventive Journey of Gary W Ashley

Introduction: Gary W Ashley, a talented inventor hailing from Alameda, CA (US), has made significant contributions to the world of innovation through his creative and groundbreaking ideas.

Latest Patents: Gary W Ashley's latest patents showcase his ingenuity in various fields such as technology, healthcare, and sustainable energy. His recent inventions have been recognized for their unique approach to solving complex problems.

Career Highlights: Throughout his illustrious career, Gary W Ashley has been at the forefront of innovation, holding key roles in research institutions and leading companies. His expertise in patent applications and cutting-edge technologies has set him apart in the industry.

Collaborations: Gary W Ashley has collaborated with top universities, research institutions, and forward-thinking companies to bring his inventions to life. His partnerships have led to groundbreaking discoveries and advancements in multiple sectors.

Conclusion: In conclusion, Gary W Ashley's passion for innovation and his relentless pursuit of excellence have solidified his position as a respected inventor in the field. His contributions continue to inspire future generations of inventors to push the boundaries of what is possible.